Skip to content

Nippon Express (China) Opens New Healthcare Branch in Shanghai

By asianet

– Company Is Stepping up Its Efforts in China’s Pharmaceutical Industry – Nippon Express (China) Co., Ltd. (hereafter “NX China”), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch in Shanghai to strengthen its efforts in China’s pharmaceutical industry, and this new branch opened for business on July 1. Logo: https://kyodonewsprwire.jp/img/202207284436-O1-Ubnp6zGP … Continued

Global Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services

By asianet

A new report [ https://www.theglobalfund.org/media/12208/core_2022-breaking-down-barriers-mid-term-assessment_summary_en.pdf ] released by the Global Fund today at the 24th International AIDS Conference unveils key findings of the activities supported by the Global Fund’s Breaking Down Barriers initiative [ https://www.theglobalfund.org/en/human-rights/ ], a groundbreaking program launched in 2017 to provide intensive financial and technical support to 20 countries* to address stigma … Continued

PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS

By asianet

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinking skills were revealed by multiple studies reported today at the Alzheimer’s Association International Conference (R) … Continued

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

By asianet

Concept Medical Inc. [https://www.conceptmedical.com/], a pioneer in developing drug delivery device platforms for vascular intervention, has announced the initiation of LIMES trial. LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug Coated Balloon versus Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease) has … Continued

Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America

By asianet

The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago. Menarini Silicon Biosystems Inc, a US company part of the Menarini Group and DIESSE Diagnostica Senese Società Benefit S.p.A., a … Continued

Henlius HANQUYOU Received TGA Approval in Australia

By asianet

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company’s business partner Cipla Limited (“Cipla”) has received the relevant registration certificates from the Therapeutic Goods Administration of Australia (“TGA”) for the approval of Henlius’ self-developed and manufactured HANQUYOU (trastuzumab, trade name in Europe: Zercepac®) with the specification of 150mg/vial in Australia under the trade names Tuzucip® … Continued

Novavax Announces Expanded Approval of Nuvaxovid(TM) COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan

By asianet

— Nuvaxovid(TM) is the first protein-based COVID-19 vaccine approved for use in adolescents in Japan Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Nuvaxovid(TM) (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare … Continued

Novavax Nuvaxovid(TM) COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17

By asianet

–Nuvaxovid(TM) is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in Australia Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the Australian Therapeutic Goods Agency (TGA) has granted expanded approval for provisional registration of Nuvaxovid(TM) (NVX-CoV2373) COVID-19 … Continued

4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 Appropriations

By asianet

— Thousands of Impacted Veterans Will Benefit from Congressional Efforts 4DMedical, the leading developer of functional imaging software for respiratory illness, today praised the U.S. House of Representatives for including language calling on the Department of Veterans Affairs to evaluate “emerging technology using existing x-ray imaging equipment to derive four-dimensional models of lung function” as … Continued